Annexon reports inducement grants to new employees under nasdaq listing rule 5635(c)(4)

Brisbane, calif., may 16, 2023 (globe newswire) -- annexon, inc. (nasdaq: annx), a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today announced that it has granted equity inducement awards to two new non-executive employees under the terms of the 2022 employment inducement award plan. the equity awards were approved on may 15, 2023, in accordance with nasdaq listing rule 5635(c)(4).
ANNX Ratings Summary
ANNX Quant Ranking